


We have established a radiochemistry research and development environment that complies with international standards. In addition to comprehensive basic chemical infrastructure—such as robust plumbing and drainage systems, precision lab benches, and high-performance fume hoods—our facilities are equipped with comprehensive radiation protection gear tailored to the characteristics of radiopharmaceuticals. This includes personal protective lead garments, high-density shielding lead bricks, closed glove boxes, and real-time radiation monitoring systems.
This space not only ensures the safety of operators and environmental protection, but also delivers technical capabilities aligned with international new drug landscapes. It effectively addresses diverse preclinical research demands and shortens the timeline from R&D to Investigational New Drug (IND) submissions.
The laboratory is equipped with multiple automated synthesis systems designed to meet the template requirements of international new drug manufacturing processes. Their functions range from short-lived diagnostic agents to highly sought-after alpha and beta-emitting therapeutic radiopharmaceuticals in precision medicine, offering comprehensive solutions from labeling research to small-scale production.

A high-efficiency automated platform optimized for stable and mature radiopharmaceutical labeling processes.

A compact automated module offering high flexibility, perfectly suited for developing diverse nuclides and research-oriented processes.
To ensure the purity and safety of our research drugs, the laboratory is equipped with two high-performance gas chromatographs (GC) dedicated to detecting residual solvents and performing quality analysis. Through precise data monitoring, we guarantee that every batch of manufactured drugs strictly complies with pharmacopoeia regulations and safety standards.
